309 related articles for article (PubMed ID: 12783075)
1. Ongoing trials of cardiac resynchronisation.
Cleland JG; Ghosh J; Khan N; Hurren S; Kaye G
Minerva Cardioangiol; 2003 Apr; 51(2):197-207. PubMed ID: 12783075
[TBL] [Abstract][Full Text] [Related]
2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
3. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
[TBL] [Abstract][Full Text] [Related]
4. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
Ansalone G; Ricci R; Cacciatore G; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
[TBL] [Abstract][Full Text] [Related]
5. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
[TBL] [Abstract][Full Text] [Related]
6. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
7. [Non-pharmacological therapy of decompensated heart failure: cardiac resynchronization therapy].
Storti C; Longobardi M; Buzzi MP; Negro MC; Pilun EB; Baldi A; Falcone C
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):123S-128S. PubMed ID: 19195320
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in heart failure patients: an update.
Jeevanantham V; Daubert JP; Zareba W
Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
[TBL] [Abstract][Full Text] [Related]
9. Cardiac resynchronization therapy: device-based medicine for heart failure.
Philippon F
J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
[TBL] [Abstract][Full Text] [Related]
10. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
[TBL] [Abstract][Full Text] [Related]
11. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
12. [Heart re-synchronization with biventricular stimulation: new treatment for refractory heart failure].
Daubert JC; Leclercq C; Mabo P
Bull Acad Natl Med; 2002; 186(1):45-55; discussion 56-7. PubMed ID: 12146141
[TBL] [Abstract][Full Text] [Related]
13. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
Pires LA
Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
[TBL] [Abstract][Full Text] [Related]
14. Biventricular pacing and defibrillator use in chronic heart failure.
Cesario DA; Turner JW; Dec GW
Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
[TBL] [Abstract][Full Text] [Related]
15. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
16. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
[TBL] [Abstract][Full Text] [Related]
17. Why should we care about CARE-HF?
Ellenbogen KA; Wood MA; Klein HU
J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
[TBL] [Abstract][Full Text] [Related]
19. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronisation therapy for heart failure.
Behan MW; Rinaldi CA
Int J Clin Pract; 2006 Sep; 60(9):1107-14. PubMed ID: 16939553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
